After losing 23% in the past year, aTyr Pharma, Inc. (NASDAQ:LIFE) institutional owners must be relieved by the recent gain [Yahoo! Finance]
aTyr Pharma, Inc. (LIFE)
Last atyr pharma, inc. earnings: 3/26 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
atyrpharma.com/investors-media
Company Research
Source: Yahoo! Finance
A total of 5 investors have a majority stake in the company with 57% ownership Insiders have bought recently A look at the shareholders of aTyr Pharma, Inc. ( NASDAQ:LIFE ) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 56% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn). Last week's US$11m market cap gain would probably be appreciated by institutional investors, especially after a year of 23% losses. In the chart below, we zoom in on the different ownership groups of aTyr Pharma. View our latest analysis for aTyr Pharma What Does The Institutional Ownership Tell Us About aTyr Pharma? Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the re
Show less
Read more
Impact Snapshot
Event Time:
LIFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIFE alerts
High impacting aTyr Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
LIFE
News
- aTyr Pharma, Inc. (NASDAQ: LIFE) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $35.00 price target on the stock.MarketBeat
- aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate UpdateGlobeNewswire
- aTyr Pharma Insiders Placed Bullish Bets Worth US$514.6k [Yahoo! Finance]Yahoo! Finance
- aTyr Pharma to Participate in April Investor ConferencesGlobeNewswire
LIFE
Earnings
- 3/14/24 - Miss
LIFE
Sec Filings
- 5/2/24 - Form 10-Q
- 5/2/24 - Form 8-K
- 4/5/24 - Form ARS
- LIFE's page on the SEC website